Evaluating Dexmedetomidine and Ketamine for Control of Post-Operative Pain in Lower Segment Caesarean Section Surgeries
DOI:
https://doi.org/10.36283/ziun-pjmd14-3/038Keywords:
Cesarean Section, Postoperative Pain , Dexmedetomidine, Ketamine , Analgesia, Patient-Controlled, Randomized Controlled TrialAbstract
Background: Effective control for postoperative pain that follows lower-segment cesarean section (LSCS) remains a clinical challenge, with the opioid-related side effects prompting the use of multimodal analgesia. Dexmedetomidine and ketamine have shown synergistic analgesic effects, but optimal dosing of dexmedetomidine in this combination is not well established. To compare the analgesic efficacy and safety of three different doses of dexmedetomidine combined with a fixed dose of ketamine for postoperative pain control after LSCS.
Methods: In this randomized controlled trial RCT Registered (NCT07022821), 90 participants undergoing elective LSCS under spinal anesthesia were assigned to one of three groups (n=30 each) from March to May 2025 at Department of Anesthesia FMH Lahore. A random sampling technique was used for sample size distribution. All received ketamine 0.25 mg/kg/hr, with Group A receiving dexmedetomidine 0.02 µg/kg/hr, Group B 0.3 µg/kg/hr, and Group C 0.4 µg/kg/hr. Infusions continued for 24 hours postoperatively. Pain was assessed using the Visual Analog Scale (VAS) at multiple intervals. Secondary outcomes included opioid consumption, time to rescue analgesia, and adverse effects. Data were analyzed using SPSS v25. p < 0.05 was considered significant.
Results: Group C consistently exhibited the lowest VAS scores across all time points (p < 0.001), significantly lower opioid use (4.1 ± 1.3 mg nalbuphine), and the longest time to first rescue analgesia (8.3 ± 2.3 hrs). Mild sedation was more frequent in Group C, but it was not clinically significant.
Conclusion: A dexmedetomidine dose of 0.4 µg/kg/hr combined with ketamine provides superior postoperative analgesia after LSCS, with reduced opioid requirements and acceptable safety. This regimen may enhance the recovery and comfort of patients in obstetric anesthesia.
References
1. Zhai W, Liu H, Yu Z, Jiang Y, Yang J, Li M. Bibliometric Analysis of Research Studies on Postoperative Pain Management of Cesarean Section. J Pain Res. 2023 Apr 21;16:1345-1353. doi: 10.2147/JPR.S404659.
2. Ollosu M, Tripodi VF, Bonu A, Cittadini G, Musu M, Ippolito M, et al. Efficacy and safety of intrathecal adjuvants for perioperative management of cesarean delivery: a systematic review and network meta-analysis of randomized controlled trials. Reg Anesth Pain Med. 2025 Mar 26:rapm-2024-106345. doi: 10.1136/rapm-2024-106345.
3. Grasch JL, Rojas JC, Sharifi M, McLaughlin MM, Bhamidipalli SS, Haas DM. Impact of Enhanced Recovery After Surgery pathway for cesarean delivery on postoperative pain. AJOG Glob Rep. 2023 Jan 29;3(1):100169. doi: 10.1016/j.xagr.2023.100169.
4. Douglas MS, Soloniuk LJ, Jones J, Derderian R, Baker C, Stier G. Intravenous dexmedetomidine use in obstetric anesthesia: a focused review. Int J Obstet Anesth. 2025 Feb 13;62:104345. doi: 10.1016/j.ijoa.2025.104345.
5. Ferraro MC, Cashin AG, O'Connell NE, Visser EJ, Abdel Shaheed C, Wewege MA, et al. Ketamine and other NMDA receptor antagonists for chronic pain. Cochrane Database Syst Rev. 2023 Feb 23;2023(2):CD015373. doi: 10.1002/14651858.CD015373.
6. Zhang D, Sun Y, Li J. Application of Dexmedetomidine in Epidural Labor Analgesia: A Systematic Review and Meta-Analysis on Randomized Controlled Trials. Clin J Pain. 2024 Jan 1;40(1):57-65. doi: 10.1097/AJP.0000000000001166.
7. Xu S, Zhou Y, Wang S, Li Q, Feng Y, Chen L, et al. Perioperative intravenous infusion of dexmedetomidine for alleviating postpartum depression after cesarean section: A meta-analysis and systematic review. Eur J Obstet Gynecol Reprod Biol. 2024 May;296:333-341. doi: 10.1016/j.ejogrb.2024.03.024.
8. Coviello A, Iacovazzo C, Frigo MG, Ianniello M, Cirillo D, Tierno G, et al. Technical aspects of neuraxial analgesia during labor and maternity care: an updated overview. J Anesth Analg Crit Care. 2025 Jan 29;5(1):6. doi: 10.1186/s44158-025-00224-3.
9. Yang JR, Li YY, Ran TJ, Lin XY, Xu JY, Zhou SL, et al. Esketamine Combined with Dexmedetomidine to reduce Visceral Pain During elective Cesarean Section Under Combined Spinal-Epidural Anesthesia: A double-Blind Randomized Controlled Study. Drug Des Devel Ther. 2024 Jun 18;18:2381-2392. doi: 10.2147/DDDT.S460924.
10. Wu YY, Fang Z, Liu KS, Li MD, Cheng XQ. Whole-course application of dexmedetomidine as an adjuvant to spinal-epidural anesthesia for cesarean section: A randomized, controlled trial. Heliyon. 2023 Dec 10;10(1):e23534. doi: 10.1016/j.heliyon.2023.e23534.
11. Li J, Fu W, Wang N, Zeng S, Li X, Wan J, et al. Effect of Dexmedetomidine on the ED50 and ED95 of Sufentanil in Patient-Controlled Intravenous Analgesia After Cesarean Section: A Randomized, Controlled, Double-Blind Trial. Drug Des Devel Ther. 2025 Jan 9;19:129-140. doi: 10.2147/DDDT.S494162.
12. Forkin KT, Mitchell RD, Chiao SS, Song C, Chronister BNC, Wang XQ, et al. Impact of timing of multimodal analgesia in enhanced recovery after cesarean delivery protocols on postoperative opioids: A single center before-and-after study. J Clin Anesth. 2022 Sep;80:110847. doi: 10.1016/j.jclinane.2022.110847.
13. Sun JJ, Wang H, Tang LL, Jiang H, Liu XS. Effect of intraoperative dexmedetomidine on recovery of gastrointestinal function after caesarean section undergoing spinal and epidural anesthesia: A randomized, double blind, placebo-controlled clinical trial. Eur J Obstet Gynecol Reprod Biol. 2024 Jun;297:30-35. doi: 10.1016/j.ejogrb.2024.03.038.
14. Ather R, Nikhar SA, Kar AK, Durga P, Prasanna PL. Comparison of the effect of intraoperative dexmedetomidine versus ketamine on postoperative analgesia in femur fracture patients operated under subarachnoid block - A prospective randomized double-blind controlled trial. J Anaesthesiol Clin Pharmacol. 2024 Oct-Dec;40(4):605-611. doi: 10.4103/joacp.joacp_67_23.
15. Mohamed SA, Sayed DM, El Sherif FA, Abd El-Rahman AM. Effect of local wound infiltration with ketamine versus dexmedetomidine on postoperative pain and stress after abdominal hysterectomy, a randomized trial. Eur J Pain. 2018 May;22(5):951-960. doi: 10.1002/ejp.1181.
16. Li WX, Luo RY, Chen C, Li X, Ao JS, Liu Y, et al. Effects of propofol, dexmedetomidine, and midazolam on postoperative cognitive dysfunction in elderly patients: a randomized controlled preliminary trial. Chin Med J (Engl). 2019 Feb;132(4):437-445. doi: 10.1097/CM9.0000000000000098.
17. Aboelsuod MAA, Elnaggar AMA, Alwafa TAAA, Ahmed MMH, Elbeltagy ASA, Elbarbary MIA. Effect of Intravenous Ketamine Infusion on Hemodynamics of Patients Undergoing Cesarean Delivery after Spinal Anaesthesia: A Randomized, Double-Blind, Controlled Trial. Turk J Anaesthesiol Reanim. 2023 Oct 24;51(5):420-426. doi: 10.4274/TJAR.2023.231231.
18. Chen HZ, Gao Y, Li KK, An L, Yan J, Li H, et al. Effect of intraoperative injection of esketamine on postoperative analgesia and postoperative rehabilitation after cesarean section. World J Clin Cases. 2024 Oct 6;12(28):6195-6203. doi: 10.12998/wjcc.v12.i28.6195.
19. Mo X, Huang F, Wu X, Feng J, Zeng J, Chen J. Intrathecal dexmedetomidine as an adjuvant to plain ropivacaine for spinal anesthesia during cesarean section: a prospective, double-blinded, randomized trial for ED50 determination using an up-down sequential allocation method. BMC Anesthesiol. 2023 Sep 25;23(1):325. doi: 10.1186/s12871-023-02275-x.
20. Chen IW, Yu TS, Hung KC. Comment on Application of Dexmedetomidine in Epidural Labor Analgesia. Clin J Pain. 2024 Apr 1;40(4):267-268. doi: 10.1097/AJP.0000000000001195.
21. Bielka K, Kuchyn I, Babych V, Martycshenko K, Inozemtsev O. Dexmedetomidine infusion as an analgesic adjuvant during laparoscopic сholecystectomy: a randomized controlled study. BMC Anesthesiol. 2018 Apr 20;18(1):44. doi: 10.1186/s12871-018-0508-6.
22. Ao L, Shi J, Bai Y, Zheng Y, Gan J. Effectiveness and safety of intravenous application of dexmedetomidine for cesarean section under general anesthesia: a meta-analysis of randomized trials. Drug Des Devel Ther. 2019 Mar 25;13:965-974. doi: 10.2147/DDDT.S197165.
23. Mondardini MC, Amigoni A, Cortellazzi P, Di Palma A, Navarra C, Picardo SG, et al. Intranasal dexmedetomidine in pediatrics: update of current knowledge. Minerva Anestesiol. 2019 Dec;85(12):1334-1345. doi: 10.23736/S0375-9393.19.13820-5.
24. Jin KX, Deng CM, Ding T, Qu Y, Wang DX. Impact of dexmedetomidine-ropivacaine versus sufentanil-ropivacaine combination for epidural labour analgesia on neonatal outcomes: a pilot randomised clinical trial. BMJ Open. 2024 Dec 22;14(12):e090208. doi: 10.1136/bmjopen-2024-090208.
25. Joshi GP. Rational Multimodal Analgesia for Perioperative Pain Management. Curr Pain Headache Rep. 2023 Aug;27(8):227-237. doi: 10.1007/s11916-023-01137-y.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
Metrics
How to Cite
